SCHEMBL7733886

SCHEMBL7733886

[CH2]CCCCCCC1CO1

nearest known ligand 0.58

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.58
EPHX1 P07099 1/20 0.38
TDP1 Q9NUW8 2/20 0.33
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2129053 1.00 ALDH1A1 (0.58) ALDH1A1EPHX1TDP1TSHR
SCHEMBL229662 1.00 ALDH1A1 (0.58) ALDH1A1EPHX1TDP1TSHR
SCHEMBL1361283 1.00 ALDH1A1 (0.58) ALDH1A1EPHX1TDP1TSHR
SCHEMBL2404833 1.00
SCHEMBL3626636 1.00 ALDH1A1 (0.58) ALDH1A1EPHX1TDP1TSHR
SCHEMBL11260441 1.00 ALDH1A1 (0.58) ALDH1A1EPHX1TDP1TSHR
SCHEMBL194136 0.97
SCHEMBL29085066 0.97
SCHEMBL229385 0.89
SCHEMBL7540476 0.86 ALDH1A1 (0.74) ALDH1A1EPHX1TDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118226707-A Photosensitive resin composition, cured film pattern, and method for producing same 奇美实业股份有限公司 2024-06-21 CN disclosed
CN-118210199-A Photosensitive resin composition, cured film pattern, and method for producing same 奇美实业股份有限公司 2024-06-18 CN disclosed
CN-118210196-A Photosensitive resin composition, cured film pattern and method for producing the same 奇美实业股份有限公司 2024-06-18 CN disclosed
CN-118210200-A Photosensitive resin composition, cured film pattern, and method for producing same 奇美实业股份有限公司 2024-06-18 CN disclosed
CN-117289549-A Photosensitive resin composition, cured film pattern, and method for producing same 奇美实业股份有限公司 2023-12-26 CN disclosed
US-20230303404-A1 NANOPARTICLES, DISPERSION OF NANOPARTICLES, AND PRODUCTION METHOD OF NANOPARTICLES TOKYO OHKA KOGYO CO., LTD. (JP) 2023-09-28 US disclosed
US-20230242692-A1 COMPOSITION AND CURED PRODUCT TOKYO OHKA KOGYO CO., LTD. (JP) 2023-08-03 US disclosed
WO-2023143988-A1 NEW COMPOUNDS AND THEIR USE AS ANTI-AGING AGENT OR AS EXERCISE ENHANCER ETH ZURICH (CH) 2023-08-03 WO disclosed
CN-116514161-A Nanoparticle, nanoparticle dispersion liquid, and method for producing nanoparticle 东京应化工业株式会社 2023-08-01 CN disclosed
CN-116515023-A Composition and cured product 东京应化工业株式会社 2023-08-01 CN disclosed
US-6417243-B1 POLYESTERURETHANE BLOCKS UCB, S.A. (BE) 2002-07-09 US disclosed
US-5554703-A Nitrogenous multiacrylic monomers, their preparation and their application to the obtention of new polymers CRAY VALLEY S.A. (FR) 1996-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303404-A1 NANOPARTICLES, DISPERSION OF NANOPARTICLES, AND PRODUCTION METHOD OF NANOPARTICLES CD63, NIBAN2, ZRANB2 ALDH1A1 2717/4885EPHX1 4651/4885TDP1 3675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.